ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
35 hedge funds and large institutions have $110M invested in Elevation Oncology in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
11% less capital invested
Capital invested by funds: $123M → $110M (-$13.1M)
Holders
35
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.5M | |
| 2 | +$132K | |
| 3 | +$129K | |
| 4 |
Jane Street
New York
|
+$126K |
| 5 |
Renaissance Technologies
New York
|
+$100K |
Top Sellers
| 1 | -$2.82M | |
| 2 | -$1.65M | |
| 3 | -$487K | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$278K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$190K |